StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Sanofi (SNY)

Form 6-K Sanofi For: Mar 31 April 25, 2024 10:51 AM - SEC Filing Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy April 25, 2024 5:30 AM - StreetInsider Sanofi (SNY) Tops Q1 EPS by 85c; reaffirms guidance April 25, 2024 4:49 AM - StreetInsider Sanofi profit slips on generic competition and currency effects April 25, 2024 1:38 AM - StreetInsider Sanofi (SAN:FP) (SNY) PT Raised to EUR114 at Bernstein SocGen Group April 24, 2024 11:02 AM - StreetInsider Sanofi (SNY) Said To Ask Banks To Pitch For Role On $20B OTC Spinoff - Bloomberg April 23, 2024 12:29 PM - StreetInsider Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia April 23, 2024 1:00 AM - Globe NewsWire Sanofi (SNY) To Pay $100 Million To Settle Zantac Cancer Lawsuits - Bloomberg April 22, 2024 10:31 AM - StreetInsider Sanofi to overhaul US operations of vaccines, cut jobs April 18, 2024 4:28 PM - StreetInsider IGM Biosciences (IGMS) Announces Refocusing of Sanofi Collaboration April 17, 2024 8:31 AM - StreetInsider Nurix Therapeutics (NRIX) Announces Extension of Strategic Collaboration with Sanofi (SNY) to Develop Novel Targeted Protein Degraders of STAT6 April 9, 2024 7:13 AM - StreetInsider Sanofi (SNY) Launches Verorab in the UK April 5, 2024 5:53 AM - StreetInsider Sanofi Announces Launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for Pre-exposure and Post-exposure Prophylaxis of Rabies in All Age Groups April 5, 2024 4:15 AM - BizWire Form F-3ASR Sanofi April 4, 2024 2:07 PM - SEC Filing Form S-8 Sanofi April 4, 2024 8:46 AM - SEC Filing Sanofi-Aventis (SNY) PT Lowered to $55 at Argus, 'BUY as FDA reviews Dupixent for COPD' April 3, 2024 12:55 PM - StreetInsider Sanofi (SNY) and AstraZeneca (AZN) announce Beyfortus approved in Japan for the prevention of RSV disease in infants March 27, 2024 5:53 AM - StreetInsider Form 6-K Sanofi For: Mar 20 March 20, 2024 2:08 PM - SEC Filing Form S-8 POS Sanofi March 15, 2024 8:41 AM - SEC Filing Form 6-K Sanofi For: Feb 27 February 27, 2024 11:36 AM - SEC Filing Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria February 24, 2024 9:51 AM - Globe NewsWire Form IRANNOTICE Sanofi February 23, 2024 2:04 PM - SEC Filing Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report February 23, 2024 12:45 PM - Globe NewsWire Form 20-F Sanofi For: Dec 31 February 23, 2024 11:19 AM - SEC Filing Sanofi's (SNY) Board Proposes Appointments of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as Directors February 22, 2024 1:03 PM - StreetInsider Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors February 22, 2024 1:02 PM - Globe NewsWire Berenberg Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) February 22, 2024 5:11 AM - StreetInsider Sanofi's (SNY) consumer health division attracting early interest from Advent, Blackstone and more - Bloomberg February 20, 2024 11:22 AM - StreetInsider Advent, Blackstone Said To Mull Bids For Sanofi (SNY) Consumer Health - Bloomberg February 20, 2024 9:20 AM - StreetInsider Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting February 20, 2024 8:30 AM - BizWire Deutsche Bank Reiterates Sell Rating on Sanofi (SAN:FP) (SNY) February 20, 2024 4:14 AM - StreetInsider Form 6-K Sanofi For: Feb 15 February 15, 2024 12:10 PM - SEC Filing Form SC 13G/A Sanofi Filed by: Amundi February 14, 2024 3:58 PM - SEC Filing Form SC 13G/A Sanofi Filed by: DODGE & COX February 13, 2024 1:55 PM - SEC Filing The European version of Magnificent 7 is trading at a 30% discount - Goldman February 12, 2024 6:01 AM - StreetInsider Sanofi (SAN:FP) (SNY) PT Raised to EUR94 at JPMorgan February 12, 2024 2:15 AM - StreetInsider Form SC 13G/A Sanofi Filed by: BlackRock Inc. February 6, 2024 3:15 PM - SEC Filing Form 6-K Sanofi For: Feb 02 February 2, 2024 1:22 PM - SEC Filing Form 6-K Sanofi For: Dec 31 February 1, 2024 9:45 AM - SEC Filing Sanofi (SNY) shares slide following Q4 revenue miss February 1, 2024 8:42 AM - StreetInsider Sanofi (SNY) Tops Q4 EPS by 74c February 1, 2024 4:49 AM - StreetInsider European stocks weaken ahead of BOE, eurozone CPI; Deutsche Bank shines February 1, 2024 4:03 AM - StreetInsider Sanofi (SNY) Tops Q4 EPS by 74c; offers FY24 guidance February 1, 2024 3:26 AM - StreetInsider Press Release: François-Xavier Roger appointed Chief Financial Officer, member of Sanofi Executive Committee February 1, 2024 1:36 AM - Globe NewsWire Press Release: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline February 1, 2024 1:36 AM - Globe NewsWire Sanofi Q4 earnings hit by weak dollar, generic competition February 1, 2024 1:36 AM - StreetInsider UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) January 31, 2024 5:06 AM - StreetInsider Synthekine Announces Strategic Collaboration with Sanofi to Develop Selective IL-10 Agonists for Treatment of Inflammatory Diseases January 29, 2024 8:00 AM - BizWire Berenberg Reiterates Buy Rating on Sanofi (SAN:FP) (SNY) January 28, 2024 3:38 AM - StreetInsider Full Article List